Both in Surgical Instruments
Embecta vs Treace Medical Concepts
Over the past year EMBC returned −58.9% and TMCI returned −31.3%; their daily moves had a correlation of 0.08.
EMBC −58.9% TMCI −31.3%Growth of $1, one year, split-adjusted
| Metric | EMBC | TMCI |
|---|---|---|
| Price | $5.76 | $4.62 |
| Market cap | $326.4M | $300.5M |
| Today | −2.87% | +3.13% |
| 1 month | +14.1% | −0.6% |
| 6 months | −34.8% | +285.0% |
| Year to date | −51.5% | +88.6% |
| 1 year | −58.6% | −30.6% |
| Revenue growth (YoY) | −8.1% | −4.2% |
| Gross margin | 56.4% | 78.5% |
| Net margin | 7.8% | −35.0% |
| P/E (TTM) | 3.7× | — |
| Price / sales | 0.3× | 1.5× |
| Net cash | -$1.27B | -$10.4M |
| Dividend yield | 0.69% | — |
| Volatility (60d) | 74.9% | 60.8% |
| Short % of float | 9.9% | 3.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).